SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 9 filers reported holding SEAGEN INC in Q4 2023. The put-call ratio across all filers is 0.99 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,743 | +11.2% | 55,354 | +0.9% | 0.08% | +11.6% |
Q2 2023 | $10,560 | +14.4% | 54,872 | +20.4% | 0.07% | +7.8% |
Q1 2023 | $9,227 | +64.0% | 45,572 | +4.1% | 0.06% | +52.4% |
Q4 2022 | $5,626 | -99.9% | 43,778 | -9.8% | 0.04% | -17.6% |
Q3 2022 | $6,640,000 | -18.3% | 48,531 | +5.6% | 0.05% | -15.0% |
Q2 2022 | $8,130,000 | +19.0% | 45,948 | -3.1% | 0.06% | +50.0% |
Q1 2022 | $6,833,000 | -22.7% | 47,433 | -15.7% | 0.04% | -13.0% |
Q4 2021 | $8,843,000 | +10.3% | 56,256 | +19.2% | 0.05% | +4.5% |
Q3 2021 | $8,015,000 | +6.2% | 47,204 | -1.2% | 0.04% | -4.3% |
Q2 2021 | $7,545,000 | -48.0% | 47,793 | -54.2% | 0.05% | -51.6% |
Q1 2021 | $14,505,000 | +70.6% | 104,452 | +115.2% | 0.10% | +63.8% |
Q4 2020 | $8,502,000 | – | 48,545 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |